Atara Biotherapeutics/$ATRA
About Atara Biotherapeutics
Ticker
Industry
Employees
ATRA Metrics
$93M
-
-$22.60
0.51
-
Price and volume
Market cap
$93M
Beta
0.51
52-week high
$39.50
52-week low
$6.50
Average daily volume
108K
Financial strength
Current ratio
0.589
Quick ratio
0.439
Long term debt to equity
-38.926
Total debt to equity
-55.115
Interest coverage (TTM)
-12.90%
Management effectiveness
Return on assets (TTM)
-45.03%
Return on equity (TTM)
188.38%
Valuation
Price to revenue (TTM)
0.95
Price to book
-1.03
Price to tangible book (TTM)
-1.03
Price to free cash flow (TTM)
-1.006
Growth
Revenue change (TTM)
2,111.34%
Earnings per share change (TTM)
-67.40%
3-year revenue growth (CAGR)
98.76%
3-year earnings per share growth (CAGR)
-37.02%
What the Analysts think about ATRA
Analyst Ratings
ATRA Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
ATRA Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
ATRA News
FAQs
What’s the current market cap for Atara Biotherapeutics stock?
What is the P/E ratio for Atara Biotherapeutics stock?
Does Atara Biotherapeutics stock pay dividends?
No, Atara Biotherapeutics (ATRA) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Atara Biotherapeutics dividend payment date?
Atara Biotherapeutics (ATRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Atara Biotherapeutics?
Atara Biotherapeutics (ATRA) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.